# PediaRounds cross-chat coordination state

Updated: 2026-09-07
Branch: `master-bank/review-images-verification`
PR: **#5 — Review images, incomplete recalls, and clinical verification**
Base: `main`

## Structural baseline
- 1023 records scanned.
- 1022/1022 enumerated source slots covered; 0 missing.
- Genetics TOC anomaly remains: TOC says 53, actual sequence ends at Q52. Do not fabricate Q53.
- Exact duplicate IDs: 0; section/Q collisions: 0.

## Completed quality milestones
- Sparse recalls: **167/167** directly re-read from source; no missing distractors/calculations invented.
- Sparse media cues: **48/48** technically reconciled.
- Outdated queue: **9/9** received current clinical review; recalled keys preserved.

## Conflicting queue — all 131 assigned
- Batch 1: `review-queue/conflicting-batch01-triage-30-20260907.json` — 30
- Batch 2: `review-queue/conflicting-batch02-triage-40-20260907.json` — 40
- Batch 3: `review-queue/conflicting-batch03-final-61-20260907.json` — 61
- **131/131 assigned; 0 unassigned.**

## Clinical conflict resolution — active
First current-guidance resolution pass committed:
- `review-queue/conflicting-clinical-resolution-batch01-12-20260907.json`

Outcome:
- **12 conflicts reviewed against current guidance/frameworks.**
- **4 resolved to a defensible modern verified answer in the retained stem/options:** Cardiology Q26 = B; Cardiology Q27 = B; Endocrinology Q55 = C under ADA 2026 criteria; Hematology Q48 = D (factor XII deficiency).
- Trauma Q10: current PECARN cervical-spine guidance supports clinical clearance without imaging in a truly low-risk child; because `no imaging` is absent from retained options, item remains non-publishable.
- Rheumatology Q7: modern JDM guidance supports symmetric proximal weakness, but the source's ascending/descending labels make the options invalid as a clean modern SBA.
- Dermatology Q12: systemic antiviral therapy is required, but oral versus IV route depends on severity/ability to take oral therapy; retained context does not uniquely settle route.
- Hematology Q50, Behavioral Q10/Q17, Research Q7/Q9 remain irreducible/under-specified as written.
- **0 recalledAnswer values overwritten.**

## Important retained gates
- Ethics Q10/Q11: current Saudi/MOH DNR policy and perioperative DNR handling required.
- Research Q7/Q9: variable coding/diagnostic-table context missing; no answer should be forced.
- Trauma Q10: modern low-risk action is absent from retained options.
- Dermatology Q12: route depends on severity; source key/explanation conflict remains.
- Gastro Q35: congenital diarrhea differential unresolved without stool electrolytes.
- Gastro Q56/Q57: original imaging/definitive-study interpretation uncertain.
- Neonatology Q36: key and explanation disagree on brachial plexus root level.
- Infectious Q116: answer depends on Saudi vaccine-schedule version.
- Nephrology Q46: image missing and source answer unresolved.

## Shared execution rules
- GitHub is the shared memory across chats.
- Do not restart completed numbered, sparse, media, outdated, conflict-assignment, or clinical-resolution batch01 work.
- Preserve `recalledAnswer` separately from `verifiedAnswer`.
- Do not invent missing options, calculations, media, years, stems, or keys.
- Original source images only; no generated substitutes for source-dependent MCQs.
- Source PDFs, credentials, and secrets must not be committed.

## Next shared batch
Continue **large clinical-resolution passes** through the assigned conflicts. Prioritize complete retained stems/options in Hematology, Endocrinology, Nephrology/Urology, Critical Care, and Rheumatology where current guidance can support a clean answer. Keep invalid/under-specified items non-publishable. After conflict-resolution passes, advance the `needs_verification` queue.

## Coordination rule
If another chat advances PR #5, refetch this file and `MASTER_BANK_PROGRESS.md` before writing and follow the newest GitHub state.
